Market open· · ZAc · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Remgro Ltd (FRA:RE7) posts strong full-year results with headline earnings up 42.3% to R11.1 billion, a R5.50 special dividend, and a transformative Mediclinic restructuring.
Readers hoping to buy Remgro Limited ( JSE:REM ) for its dividend will need to make their move shortly, as the stock is...
The simplest way to invest in stocks is to buy exchange traded funds. But the truth is, you can make significant gains...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.